Man Group
RGNX icon

Man Group’s Regenxbio RGNX Stock Holding History

Man Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-187,625
Closed -$1.57M – 2567
2026
Q1 		$1.57M Buy
187,625
+124,054
+195% +$1.3M ﹤0.01% 1670
2025
Q4 		$915K Sell
63,571
-48,827
-43% -$609K ﹤0.01% 1696
2025
Q3 		$1.08M Buy
112,398
+27,599
+33% +$244K ﹤0.01% 1639
2025
Q2 		$696K Buy
84,799
+52,592
+163% +$440K ﹤0.01% 1722
2025
Q1 		$230K Buy
+32,207
New +$240K ﹤0.01% 1998
2024
Q4 		– Sell
-12,652
Closed -$133K – 2160
2024
Q3 		$133K Buy
+12,652
New +$154K ﹤0.01% 1888
2023
Q3 		– Sell
-62,207
Closed -$1.13M – 1493
2023
Q2 		$1.24M Buy
+62,207
New +$1.2M ﹤0.01% 1328
2023
Q1 		– Sell
-101,017
Closed -$2.24M – 1170
2022
Q4 		$2.29M Buy
101,017
+40,017
+66% +$905K 0.01% 1087
2022
Q3 		$1.61M Buy
+61,000
New +$1.81M 0.01% 1145
2022
Q2 		– Sell
-7,900
Closed -$197K – 1268
2022
Q1 		$262K Buy
+7,900
New +$219K ﹤0.01% 1820
2021
Q2 		– Sell
-5,900
Closed -$201K – 2072
2021
Q1 		$201K Sell
5,900
-31,400
-84% -$1.34M ﹤0.01% 1747
2020
Q4 		$1.69M Buy
37,300
+15,211
+69% +$532K 0.01% 1258
2020
Q3 		$607K Sell
22,089
-56,754
-72% -$1.85M ﹤0.01% 1503
2020
Q2 		$2.9M Buy
+78,843
New +$2.94M 0.01% 909
2019
Q3 		– Sell
-40,794
Closed -$2.1M – 1896
2019
Q2 		$2.1M Sell
40,794
-13,160
-24% -$657K 0.01% 1291
2019
Q1 		$3.09M Buy
53,954
+2,715
+5% +$134K 0.01% 1152
2018
Q4 		$2.15M Buy
51,239
+21,671
+73% +$1.27M 0.01% 1186
2018
Q3 		$2.23M Buy
29,568
+24,830
+524% +$1.79M 0.01% 1373
2018
Q2 		$340K Buy
+4,738
New +$226K ﹤0.01% 1895

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Man Group's RGNX Position: Q2 2026 in Review

Man Group sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 187,625 shares — an estimated $1.57M sold.

Man Group first reported a position in RGNX in Q2 2018 and held it in 19 quarters. The position peaked at $3.09M in Q1 2019. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Man Group reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 187,625 Regenxbio shares in Q2 2026, an estimated $1.57M.
  • Man Group first reported a position in Regenxbio in Q2 2018 and held it in 19 quarters.
  • Man Group's Regenxbio position peaked at $3.09M in Q1 2019.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.